Sean Pinney to Treatment Outcome
This is a "connection" page, showing publications Sean Pinney has written about Treatment Outcome.
Connection Strength
0.823
-
Outcomes based on blood pressure in patients on continuous flow left ventricular assist device support: An Interagency Registry for Mechanically Assisted Circulatory Support analysis. J Heart Lung Transplant. 2020 05; 39(5):441-453.
Score: 0.074
-
The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2013 Aug; 6(4):668-74.
Score: 0.048
-
Clinical outcomes following heart transplantation. Mt Sinai J Med. 2012 May-Jun; 79(3):317-29.
Score: 0.044
-
Disseminated intravascular coagulation complicating Epstein-Barr virus infection in a cardiac transplant recipient: a case report. Transplant Proc. 2010 Jun; 42(5):1973-5.
Score: 0.038
-
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant. 2005 Jan; 24(1):34-7.
Score: 0.026
-
Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
Score: 0.024
-
Transcatheter Left Ventricular Restoration in Patients With Heart Failure. J Card Fail. 2023 07; 29(7):1046-1055.
Score: 0.023
-
Clinical outcomes of grafted vs. percutaneous axillary intra-aortic balloon pump support as a bridge to transplantation: a propensity score-matched analysis. Heart Vessels. 2022 Dec; 37(12):1995-2001.
Score: 0.022
-
Center Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial. J Card Fail. 2022 07; 28(7):1158-1168.
Score: 0.022
-
Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar. J Am Coll Cardiol. 2022 03 22; 79(11):1092-1107.
Score: 0.022
-
De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices. Transpl Immunol. 2022 06; 72:101567.
Score: 0.022
-
Significant vascular complications in percutaneous axillary intra-aortic balloon pump. Ann Vasc Surg. 2022 Jul; 83:42-52.
Score: 0.021
-
Implications of Heart Rate in Patients with Left Ventricular Assist Devices. Int Heart J. 2022; 63(1):56-61.
Score: 0.021
-
STS INTERMACS Database: The Key to Conduct Single-Arm Trials in Advanced Heart Failure Patients. Ann Thorac Surg. 2022 03; 113(3):808-815.
Score: 0.020
-
Challenges in heart transplantation during COVID-19: A single-center experience. J Heart Lung Transplant. 2020 09; 39(9):894-903.
Score: 0.019
-
Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J Am Coll Cardiol. 2020 08 04; 76(5):533-546.
Score: 0.019
-
Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure. JAMA Cardiol. 2020 06 01; 5(6):652-659.
Score: 0.019
-
American Association for Thoracic Surgery/International Society for Heart and Lung Transplantation guidelines on selected topics in mechanical circulatory support. J Thorac Cardiovasc Surg. 2020 03; 159(3):865-896.
Score: 0.019
-
Gene expression profiling and racial disparities in outcomes after heart transplantation. J Heart Lung Transplant. 2019 08; 38(8):820-829.
Score: 0.018
-
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
Score: 0.017
-
Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant. 2019 05; 19(5):1518-1528.
Score: 0.017
-
Mitral valve repair for severe mitral valve regurgitation during left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2019 05; 157(5):1841-1848.e1.
Score: 0.017
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Score: 0.017
-
Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock. J Thorac Cardiovasc Surg. 2018 03; 155(3):1059-1068.
Score: 0.016
-
Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. J Heart Lung Transplant. 2018 01; 37(1):15-24.
Score: 0.016
-
The Relationship Between Psychological Symptoms and Ventricular Assist Device Implantation. J Pain Symptom Manage. 2017 12; 54(6):870-876.e1.
Score: 0.016
-
Outcomes of Ventricular Tachycardia Ablation Using Percutaneous Left Ventricular Assist Devices. Circ Arrhythm Electrophysiol. 2017 Jun; 10(6).
Score: 0.016
-
Dynamic Changes in LV Radius as a Marker of Septal Configuration for Predicting RV Failure Following LVAD Implantation. JACC Cardiovasc Imaging. 2017 05; 10(5):598-599.
Score: 0.015
-
Pain and Functional Status in Patients With Ventricular Assist Devices. J Pain Symptom Manage. 2016 10; 52(4):483-490.e1.
Score: 0.015
-
Heart transplantation in a patient with heteroresistant vancomycin-intermediate Staphylococcus aureus ventricular assist device mediastinitis and bacteremia. Transpl Infect Dis. 2013 Oct; 15(5):E177-81.
Score: 0.012
-
Successful use of a donor heart with quadricuspid aortic valve for orthotopic heart transplantation. J Card Surg. 2013 Jul; 28(4):467-8.
Score: 0.012
-
Implantable left ventricular assist devices as initial therapy for refractory postmyocardial infarction cardiogenic shock. Eur J Cardiothorac Surg. 2013 Aug; 44(2):213-6.
Score: 0.012
-
Bench mitral valve repair of donor hearts before orthotopic heart transplantation. Circ Heart Fail. 2012 Nov; 5(6):e96-7.
Score: 0.011
-
Failed repeated thrombolysis requiring left ventricular assist device pump exchange. Catheter Cardiovasc Interv. 2013 May; 81(6):1072-4.
Score: 0.011
-
Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg. 2012 Jan; 41(1):213-7.
Score: 0.011
-
Excellent outcomes with use of synthetic vascular grafts for treatment of mycotic aortic pseudoaneurysms after heart transplantation. Ann Thorac Surg. 2011 Dec; 92(6):2112-6.
Score: 0.011
-
Successful use of continuous flow ventricular assist device in a patient with mechanical mitral and aortic valve prosthesis without replacement or exclusion of valves. Interact Cardiovasc Thorac Surg. 2010 Feb; 10(2):325-7.
Score: 0.009
-
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg. 2008 Sep; 107(3):962-4.
Score: 0.008
-
Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg. 2007 Oct; 84(4):1405-7.
Score: 0.008
-
Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation. J Heart Lung Transplant. 2007 Nov; 26(11):1084-90.
Score: 0.008
-
Long-term results of tacrolimus monotherapy in cardiac transplant recipients. J Heart Lung Transplant. 2006 Jun; 25(6):699-706.
Score: 0.007
-
Anti-human leukocyte antigen antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation. 2005 Jun 15; 79(11):1581-7.
Score: 0.007
-
Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg. 2004 Oct; 78(4):1352-61; discussion 1352-61.
Score: 0.006
-
Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003 Jul 08; 108(1):48-53.
Score: 0.006